Neoadjuvant tislelizumab combined with APF for patients with locally advanced head and neck squamous cell carcinoma: A prospective single-arm clinical trial

被引：0
|
作者：
Yan, Jing
Wang, Kong-cheng
Yang, Mi
Gu, Ya-Jun
Huang, Bin
Zhu, Yahui
Sha, Hui-zi
Zhu, Jing
Zhu, Chan
Chen, Dong-sheng
Qian, Xiao-Yun
Shen, Xiao-hui
Chen, Hong
机构：
[1] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Ctr Comprehens Canc, Nanjing, Peoples R China
[2] Nanjing Univ, Clin Canc Inst, Nanjing, Peoples R China
[3] Nanjing Med Univ, Nanjing Drum Tower Hosp, Clin Coll, Nanjing, Peoples R China
[4] Jiangsu Simcere Diagnost Co Ltd, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6080
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial
    Zhang, Zhanjie
    Wu, Bian
    Peng, Gang
    Xiao, Guixiang
    Huang, Jing
    Ding, Qian
    Yang, Chengzhang
    Xiong, Xingao
    Ma, Hui
    Shi, Liangliang
    Yang, Jinsong
    Hong, Xiaohua
    Wei, Jielin
    Qin, You
    Wan, Chao
    Zhong, Yi
    Zhou, Yan
    Zhao, Xueyan
    Leng, Yangming
    Zhang, Tao
    Wu, Gang
    Yao, Min
    Zhang, Xiaomeng
    Yang, Kunyu
    CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3268 - 3276
  • [2] Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: A single-arm, phase II trial
    Wu, Wenjie
    Yao, Jie
    Zhang, Tong
    Zhang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Preoperative neoadjuvant chemoimmunotherapy for locally advanced head and neck squamous cell carcinoma patients: A prospective, single-arm, phase II clinical study
    Han, P.
    Huang, X.
    Liang, F.
    Lin, P.
    Chen, R.
    Wu, T.
    Li, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S619 - S619
  • [4] Safety and efficacy of neoadjuvant therapy with tislelizumab plus chemotherapy for locally advanced head and neck squamous cell carcinoma: a single-arm, retrospective study
    Liang, Haifeng
    Liang, Wenting
    Tian, Jiawang
    Zheng, Shibei
    Su, Yangzhou
    Huang, Piao
    Chen, Renhui
    Guan, Zhong
    Cai, Qian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (03)
  • [5] Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)
    Huang, Yingying
    Sun, Jingjing
    Li, Jun
    Zhu, Dongwang
    Dong, Minjun
    Dou, Shengjin
    Tang, Yong
    Shi, Wentao
    Sun, Qi
    Zhao, Tongchao
    Zhou, Zhihang
    Zhou, Xinyu
    Liu, Ying
    Li, Jiang
    Zhu, Guopei
    Zhang, Ding
    Chen, Yanan
    Zhu, Qi
    Ju, Wutong
    Zhong, Laiping
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (08) : 2220 - 2227
  • [6] Clinical/biomarker data for neoadjuvant tislelizumab (TIS) plus chemotherapy (Chemo) in resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A single-arm, phase II trial
    Li, Q.
    Cai, L.
    Kuang, D.
    Pan, C.
    Zhao, J.
    Huang, P.
    He, C.
    Xu, K.
    Liu, D.
    Long, G.
    Liu, Z.
    Hu, G.
    Lu, X.
    ANNALS OF ONCOLOGY, 2024, 35 : S621 - S622
  • [7] Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): An open-label, single-arm, phase 2 study
    Wei, Zhigong
    Chen, Huijiao
    Cai, Lei
    Chen, Fei
    Liu, Jun
    Peng, Xingchen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial
    Huang, Xiaotao
    Liu, Qiaodan
    Zhong, Guihua
    Peng, Yingpeng
    Liu, Ye
    Liang, Lizhong
    Hong, Haiyu
    Feng, Weineng
    Yang, Shuang
    Zhang, Yaqin
    Xian, Shiping
    Li, Zhanyu
    Zhou, Yuling
    Zhang, Zhaoyuan
    Jiang, Wen
    Liang, Jun
    Liu, Zhi-gang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [9] Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial
    Xiaotao Huang
    Qiaodan Liu
    Guihua Zhong
    Yingpeng Peng
    Ye Liu
    Lizhong Liang
    Haiyu Hong
    Weineng Feng
    Shuang Yang
    Yaqin Zhang
    Shiping Xian
    Zhanyu Li
    Yuling Zhou
    Zhaoyuan Zhang
    Wen Jiang
    Jun Liang
    Zhi-gang Liu
    Journal of Experimental & Clinical Cancer Research, 41
  • [10] Prediction for major pathologic response after neoadjuvant tislelizumab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma by RNA sequencing: A single-arm, phase II trial
    Guo, Wei
    Wang, YingJian
    He, Yan
    Li, Kunkun
    Bao, Tao
    He, Xiandong
    Xie, Xianfeng
    Chen, Xv
    Pu, Xiangshu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345